JP2008518591A5 - - Google Patents

Download PDF

Info

Publication number
JP2008518591A5
JP2008518591A5 JP2007538349A JP2007538349A JP2008518591A5 JP 2008518591 A5 JP2008518591 A5 JP 2008518591A5 JP 2007538349 A JP2007538349 A JP 2007538349A JP 2007538349 A JP2007538349 A JP 2007538349A JP 2008518591 A5 JP2008518591 A5 JP 2008518591A5
Authority
JP
Japan
Prior art keywords
adenovirus
transcription unit
amplicon
derived
tet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007538349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518591A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/011629 external-priority patent/WO2006048215A1/en
Publication of JP2008518591A publication Critical patent/JP2008518591A/ja
Publication of JP2008518591A5 publication Critical patent/JP2008518591A5/ja
Withdrawn legal-status Critical Current

Links

JP2007538349A 2004-11-02 2005-10-27 複製欠損アデノウイルスベクターの製造のためのアデノウイルスアンプリコンおよびプロデューサー細胞、その製造方法および用途 Withdrawn JP2008518591A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62445904P 2004-11-02 2004-11-02
PCT/EP2005/011629 WO2006048215A1 (en) 2004-11-02 2005-10-27 Adenoviral amplicon and producer cells for the production of replication-defective adenoviral vectors, methods of preparation and use thereof

Publications (2)

Publication Number Publication Date
JP2008518591A JP2008518591A (ja) 2008-06-05
JP2008518591A5 true JP2008518591A5 (https=) 2008-12-11

Family

ID=35705355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538349A Withdrawn JP2008518591A (ja) 2004-11-02 2005-10-27 複製欠損アデノウイルスベクターの製造のためのアデノウイルスアンプリコンおよびプロデューサー細胞、その製造方法および用途

Country Status (5)

Country Link
US (1) US20070298498A1 (https=)
EP (1) EP1809753A1 (https=)
JP (1) JP2008518591A (https=)
CA (1) CA2585523A1 (https=)
WO (1) WO2006048215A1 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100285050A1 (en) 2007-10-05 2010-11-11 Isis Innovation Limited Compositions and Methods
GB0719526D0 (en) 2007-10-05 2007-11-14 Isis Innovation Compositions and methods
US20100183558A1 (en) 2008-10-17 2010-07-22 Zhennan Lai Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
CN102884196B (zh) * 2010-04-01 2015-05-06 肖卫东 重组病毒载体的结构及其制备
JP6735288B2 (ja) * 2015-04-14 2020-08-05 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． 双方向性プロモーターを有する２つの導入遺伝子を発現する組換えアデノウイルス
WO2016200997A1 (en) 2015-06-10 2016-12-15 America Gene Technologies International, Inc. Non-integrating viral delivery system and methods of use thereof
EP3319631A4 (en) 2015-07-08 2019-01-09 American Gene Technologies International Inc. HIV PREMUNICATION AND IMMUNOTHERAPY
CN116064678A (zh) 2016-01-15 2023-05-05 美国基因技术国际有限公司 用于活化γ-δT细胞的方法和组合物
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
WO2017139065A1 (en) 2016-02-08 2017-08-17 American Gene Technologies International Inc. Hiv vaccination and immunotherapy
WO2017156311A2 (en) 2016-03-09 2017-09-14 American Gene Technologies International Inc. Combination vectors and methods for treating cancer
EP3468617A4 (en) * 2016-06-08 2020-01-22 American Gene Technologies International Inc. SYSTEM FOR THE NON-INTEGRAL VIRAL ISSUE AND PROCEDURE RELATING TO IT
KR101897499B1 (ko) 2016-06-14 2018-10-04 배재대학교 산학협력단 재조합 단백질 발현 증진을 위한 유전자 절편을 포함하는 발현 벡터
AU2017292582C1 (en) 2016-07-08 2021-11-11 American Gene Technologies International Inc. HIV pre-immunization and immunotherapy
EP3487507A4 (en) 2016-07-21 2020-04-08 American Gene Technologies International, Inc. VIRAL VECTORS FOR THE TREATMENT OF PARKINSON'S DISEASE
US11820999B2 (en) 2017-04-03 2023-11-21 American Gene Technologies International Inc. Compositions and methods for treating phenylketonuria
JP2020524996A (ja) 2017-06-16 2020-08-27 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド ヒトガンマデルタｔ細胞を介する腫瘍細胞傷害性の活性化のための方法および組成物
AU2018356538B2 (en) * 2017-10-25 2023-09-28 Nouscom Ag Eukaryotic cell line
CN113573741B (zh) * 2019-03-20 2024-07-26 国立大学法人北海道大学 修饰腺病毒和含有其的医药
KR20220144416A (ko) 2020-02-04 2022-10-26 큐어백 아게 코로나바이러스 백신
CN112206318B (zh) * 2020-03-16 2021-08-03 广州恩宝生物医药科技有限公司 一种用于预防SARS-CoV-2感染的Ad7载体疫苗
EP4127193A4 (en) * 2020-03-28 2024-05-01 Greffex, Inc. MAINTENANCE OF DNA FRAGMENTS IN EUKARYOTIC CELLS, APPROACHES AND USES
US20230210979A1 (en) * 2020-04-20 2023-07-06 Greffex, Inc. Engineering broadly reactive coronavirus vaccines and related designs and uses
CA3170740A1 (en) 2020-05-29 2021-12-02 Curevac Ag Nucleic acid based combination vaccines
WO2022023559A1 (en) 2020-07-31 2022-02-03 Curevac Ag Nucleic acid encoded antibody mixtures
EP4157344A2 (en) 2020-08-31 2023-04-05 CureVac SE Multivalent nucleic acid based coronavirus vaccines
EP4565604A2 (en) 2022-08-01 2025-06-11 Flagship Pioneering Innovations VII, LLC Immunomodulatory proteins and related methods
WO2024151583A2 (en) 2023-01-09 2024-07-18 Flagship Pioneering Innovations Vii, Llc Vaccines and related methods
WO2024220746A2 (en) 2023-04-21 2024-10-24 Flagship Pioneering Innovations Vii, Llc Rnai agents targeting fatty acid synthase and related methods
KR20260044217A (ko) 2023-07-25 2026-04-01 플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 Cas 엔도뉴클레아제 및 관련 방법
CN117089577B (zh) * 2023-08-21 2024-06-25 暨南大学 重组的猴腺病毒、病毒载体及构建方法
WO2025128953A1 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
WO2025129001A1 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
WO2025129034A2 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
WO2025128943A1 (en) 2023-12-15 2025-06-19 Flagship Pioneering Innovations Vii, Llc Esterases and related methods
TW202545974A (zh) 2024-01-26 2025-12-01 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 免疫受體抑制蛋白及相關方法
WO2025217275A2 (en) 2024-04-10 2025-10-16 Flagship Pioneering Innovations Vii, Llc Immune cell targeted compositions and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002538758A (ja) * 1998-02-17 2002-11-19 ジェンザイム・コーポレイション 偽アデノウイルスベクターの製造方法
US7598362B2 (en) * 2001-10-11 2009-10-06 Merck & Co., Inc. Hepatitis C virus vaccine

Similar Documents

Publication Publication Date Title
JP2008518591A5 (https=)
JP5097714B2 (ja) Ｅ１領域内の発現カセットと不活性化されたｅ２ｂポリメラーゼを有するアデノウイルス発現ベクター
EP0988389B1 (en) Method for the production of non-group c adenoviral vectors
US20040002060A1 (en) Fiber shaft modifications for efficient targeting
WO1999053089A1 (en) Recombinant adenovirus gene transfer vector
JP2000514312A (ja) ヘルパーウイルスとヘルパー依存性ベクターとから作製した改善されたアデノウイルスベクター
CA2779632A1 (en) Simian adenovirus and methods of use
JP2009523007A5 (https=)
CN111218477B (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
CN102212554B (zh) 肠道病毒71型感染性克隆及构建方法
AU752284B2 (en) Methods for pseudoadenoviral vector production
JP2011507515A5 (https=)
JP2008505626A5 (https=)
Hartigan-O'Connor et al. Efficient rescue of gutted adenovirus genomes allows rapid production of concentrated stocks without negative selection
JP2023521149A5 (https=)
Sheppard et al. The major late promoter and bipartite leader sequence of fowl adenovirus
CN107034232B (zh) Atg16l1基因在增强新城疫病毒的复制能力中的用途
JP2024501841A (ja) アデノウイルス血清型３５ヘルパーベクター
JP2009077737A5 (https=)
JP2005518199A5 (https=)
CN121826049A (zh) 水稻胚乳特异性启动子pROLM24的分子克隆及其应用
CN103131701B (zh) 一种改进的人延长因子1α启动子
CN116981469A (zh) 腺病毒血清型35辅助载体
CN110577968A (zh) 一种新型腺病毒载体的构建和生产方法
JP2023520610A (ja) 真核細胞におけるｄｎａ断片の維持、手法、および使用